Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026)
Solid Biosciences' (SLDB) quarterly Prepaid Assets came in at $15.5 million in Q1 2026, up 138.33% year-on-year from $6.5 million in Q1 2025, and down 5.58% quarter-over-quarter from $16.4 million in Q4 2025.
Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026) Analysis & Trends
Solid Biosciences has disclosed Prepaid Assets across 10 years of filings, most recently posting $15.5 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $15.5 million, up 138.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.5 million (up 138.33% YoY), and the FY2025 annual result was $16.4 million, up 95.47% from the prior year.
- Prepaid Assets came in at $15.5 million for Q1 2026 at Solid Biosciences, down from $16.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $18.5 million in Q1 2022 to a low of $5.1 million in Q1 2023.
- The 5-year median for Prepaid Assets is $7.3 million (2024), against an average of $8.9 million.
- Across the five-year window, Prepaid Assets jumped 236.06% in 2022 and slumped 72.52% in 2023, its largest moves.
- Solid Biosciences' Prepaid Assets stood at $5.9 million in 2022, then increased by 3.01% to $6.1 million in 2023, then jumped by 37.55% to $8.4 million in 2024, then soared by 95.47% to $16.4 million in 2025, then dropped by 5.58% to $15.5 million in 2026.
- The last three Prepaid Assets figures came in at $15.5 million (Q1 2026), $16.4 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.47 Mn |
| Dec 31, 2025 | 16.38 Mn |
| Sep 30, 2025 | 8.71 Mn |
| Jun 30, 2025 | 10.53 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Sep 30, 2023 | 5.46 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 5.12 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Mar 31, 2022 | 18.54 Mn |
| Dec 31, 2021 | 14.72 Mn |
| Sep 30, 2021 | 8.37 Mn |
| Jun 30, 2021 | 5.74 Mn |